Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients.
Lahtinen AK, Koski J, Ritari J, Hyvärinen K, Koskela S, Partanen J, Vettenranta K, Koskenvuo M, Niittyvuopio R, Salmenniemi U, Itälä-Remes M, Jahnukainen K, Kilpivaara O, Wartiovaara-Kautto U. Lahtinen AK, et al. Among authors: salmenniemi u. Bone Marrow Transplant. 2023 Jan;58(1):39-45. doi: 10.1038/s41409-022-01828-x. Epub 2022 Oct 4. Bone Marrow Transplant. 2023. PMID: 36195768 Free PMC article.
[Stem cell transplantation in myelofibrosis].
Toivari A, Itälä-Remes M, Kauppila M, Putkonen M, Salmenniemi U, Remes K. Toivari A, et al. Among authors: salmenniemi u. Duodecim. 2011;127(22):2375-82. Duodecim. 2011. PMID: 22238916 Finnish.
Good responses but high TRM in adult patients after MSC therapy for GvHD.
Salmenniemi U, Itälä-Remes M, Nystedt J, Putkonen M, Niittyvuopio R, Vettenranta K, Korhonen M. Salmenniemi U, et al. Bone Marrow Transplant. 2017 Apr;52(4):606-608. doi: 10.1038/bmt.2016.317. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941780 Clinical Trial. No abstract available.
Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety.
Keto J, Kaartinen T, Salmenniemi U, Castrén J, Partanen J, Hänninen A, Korhonen M, Lähteenmäki K, Itälä-Remes M, Nystedt J. Keto J, et al. Among authors: salmenniemi u. Mol Ther Methods Clin Dev. 2018 Feb 8;9:109-118. doi: 10.1016/j.omtm.2018.02.001. eCollection 2018 Jun 15. Mol Ther Methods Clin Dev. 2018. PMID: 29516024 Free PMC article.
89 results